Biome Signs Australian Manufacturing Agreement
Filed with ASX · · 7 pages · English
Summary by 6ix AI
Biome Australia Ltd has signed a commercial manufacturing agreement with Specialty Probiotics Australia to bring the production of its Activated Probiotics range onshore, enhancing its competitive advantage in the market. The agreement requires no upfront capital investment from Biome and is expected to improve working capital and gross margins over time. The first commercial batch is targeted for production in the near future, with a full transition planned over the following months.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallIn the deck
Earlier from Biome Australia
- BMB18 clinical trial expands to dual site
- Probiotical Exclusive Supply Agreement Extended
- Patent Application Filed for Probiotic Strain BMB18
- Biome First Half FY26 Results and Highlights
- Appendix 4D & Half Yearly Report
Later from Biome Australia
- FY26 Trading Update
- International Markets Presentation
- Quarterly Activities & Cashflow Report
- Preliminary Final Report
- Biome to Launch in China
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia